DK111748B - Process for the preparation of 3β-hydroxy- or -acyloxy-Δ <5 (10)> steroids. - Google Patents

Process for the preparation of 3β-hydroxy- or -acyloxy-Δ <5 (10)> steroids.

Info

Publication number
DK111748B
DK111748B DK197363A DK197363A DK111748B DK 111748 B DK111748 B DK 111748B DK 197363 A DK197363 A DK 197363A DK 197363 A DK197363 A DK 197363A DK 111748 B DK111748 B DK 111748B
Authority
DK
Denmark
Prior art keywords
acyloxy
steroids
hydroxy
preparation
Prior art date
Application number
DK197363A
Other languages
Danish (da)
Inventor
R Takasaki
K Sakai
Y Morisawa
R Hayashi
T Hashimoto
T Nakazawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of DK111748B publication Critical patent/DK111748B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
DK197363A 1962-04-28 1963-04-27 Process for the preparation of 3β-hydroxy- or -acyloxy-Δ <5 (10)> steroids. DK111748B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP1717862 1962-04-28
JP1717962 1962-04-28
JP1718262 1962-04-28
JP2774762 1962-07-06
JP375663 1963-01-26
JP375763 1963-01-26

Publications (1)

Publication Number Publication Date
DK111748B true DK111748B (en) 1968-10-07

Family

ID=27547794

Family Applications (1)

Application Number Title Priority Date Filing Date
DK197363A DK111748B (en) 1962-04-28 1963-04-27 Process for the preparation of 3β-hydroxy- or -acyloxy-Δ <5 (10)> steroids.

Country Status (4)

Country Link
CH (1) CH500962A (en)
DE (1) DE1468637A1 (en)
DK (1) DK111748B (en)
SE (1) SE317372B (en)

Also Published As

Publication number Publication date
SE317372B (en) 1969-11-17
CH500962A (en) 1970-12-31
DE1468637A1 (en) 1969-01-02

Similar Documents

Publication Publication Date Title
DK115403B (en) Process for the preparation of (3-amino-pyrazinoyl) -guanidines.
DK111956B (en) Process for the preparation of 3,5-dioxo-17β-hydroxy-4,5-seco-Δ &lt;9&gt; ester.
DK104675C (en) Process for the preparation of 3-hydroxy-N-nitro-picolinamide.
DK105157C (en) Process for the preparation of Δ &lt;1,4&gt; -16-α-methyl steroids.
DK104346C (en) Process for the preparation of 6-methylene-3-oxo-Δ &lt;4&gt; steroids.
DK111447B (en) Process for the preparation of 17α-vinyl-5 (10) -ester-17β-ol-3-one.
DK111487B (en) Process for the preparation of 17β-hydroxy- or 17β-alkanoyloxy-3-keto-Δ &lt;4.8 (14), 9&gt; -gonatrienes.
DK103476C (en) Process for the preparation of 2-oxa-3-oxo-steroids.
DK109329C (en) Process for the preparation of Δ &lt;4&gt; -6α-alkyl-19-nor-pregnenes.
DK106090C (en) Process for the preparation of 3-halogen-Δ &lt;5&gt; -19-nor-androstenes.
DK111748B (en) Process for the preparation of 3β-hydroxy- or -acyloxy-Δ &lt;5 (10)&gt; steroids.
DK108915C (en) Process for the preparation of 21-acyloxy-acetyloxy-corticosteroids.
DK103512C (en) Process for the preparation of 3-nitroso-2-oxazolidone.
DK105401C (en) Process for the preparation of 3-oxo-Δ &lt;4&gt; -6-methyl steroids.
DK104786C (en) Process for the preparation of 6-methyl-3-oxo-Δ &lt;4.6&gt; steroids.
DK104065C (en) Process for the preparation of 3-phenylgranate (2) derivatives.
DK105336C (en) Process for the preparation of 3-oxo-17-hydroxy-13β-alkyl-Δ &lt;5 (10)&gt; gones.
DK112380B (en) Process for the preparation of 6-methyl-3-oxo-Δ &lt;4,7&gt; steroids from the pregnane series.
DK104063C (en) Process for the preparation of 4-hydroxy-5-halopyrimidines.
DK113647B (en) Process for the preparation of 2-sulfanilamido-5-methoxypyrimidine.
DK116997B (en) Process for the preparation of Δ &lt;17 (20)&gt; pregnenes.
DK99307C (en) Process for the preparation of 3-oxo-10β-methyl-13β-n-propyl-Δ &lt;4.9 (11)&gt; steroids.
DK117067B (en) Process for the preparation of Δ &lt;4&gt; -3-ketosteroids.
DK96177C (en) Process for the preparation of 4-fluor-3-keto-Δ &lt;4&gt; steroids.
DK97077C (en) Process for the preparation of 4-hydroxy- or 4-acyloxy-3-keto-Δ &lt;4&gt; steroids.